Oral Solid Dosage Contract Manufacturing Market Size to Reach USD 60.23 Billion by 2033; Growth is Driven by the Strict Regulatory Compliance Globally

U.S. Oral Solid Dosage Contract Manufacturing Market was Valued at USD 9.59 Billion in 2025E and is Expected to Reach USD 14.90 Billion by 2033 Owing to Heavy Investments in Infrastructure Globally

Austin, Feb. 19, 2026 (GLOBE NEWSWIRE) — According to SNS Insider, The Oral Solid Dosage Contract Manufacturing Market size was valued at USD 38.12 billion in 2025E and is expected to reach USD 60.23 billion by 2033, growing at a CAGR of 5.92% over 2026-2033. The global oral solid dosage contract manufacturing market is a precedent for the demand for stringent regulatory compliance. 

The need for strict regulatory compliance is exemplified by the global oral solid dosage contract manufacturing market. Manufacturers can access a wide range of international markets and ensure the safety and quality of their products by adhering to global standards. It creates credibility with investors and healthcare professionals, establishes a reputation, and makes strategic international expansion easier.

Oral Solid Dosage Contract Manufacturing Market Size and Forecast:

• Market Size in 2025E: USD 38.12 Billion
• Market Size by 2033: USD 60.23 Billion
• CAGR: 5.92% from 2026 to 2033
• Base Year: 2025E
• Forecast Period: 2026–2033
• Historical Data: 2022–2024

Get a Sample Report of Oral Solid Dosage Contract Manufacturing Market Growth Strategy @ https://www.snsinsider.com/sample-request/9015

The U.S. Oral Solid Dosage Contract Manufacturing Market was valued at USD 9.59 billion in 2025E and is expected to reach USD 14.90 billion by 2033, growing at a CAGR of 5.70% over 2026-2033. 

Established pharmaceutical corporations that make significant investments in automation, infrastructure, and regulatory compliance control the oral solid dose contract manufacturing business in the U.S.

Advancements in Drug Delivery Technologies to Propel Market Expansion

Drug delivery system innovations are essential to the industry for contract production of oral solid dosages. Innovations, such as 3D printing, targeted release, and prolonged release can increase the effectiveness of the medication, patient compliance, and manufacturing efficiency. These innovative tools enable complex preparations, reduce side effects, and are intended for customized treatments, especially for cancer and chronic drugs. They can support the expansion of outsourcing when paired with legislative support and increased demand for specialist products. As a result, both in regulated and emerging markets, the oral solid dosage contract manufacturing market share sector continues to expand.

Oral Solid Dosage Contract Manufacturing Market Segmentation Analysis:

By Product

Tablets were the dominant segment in the Oral Solid Dosage Contract Manufacturing Market analysis, with a 55.70% market share in 2025, owing to their low cost, simple administration, long shelf life, and good patient adherence. The Capsules are emerging as the fastest growing segment in the global oral solid dosage contract manufacturing market trend, with a CAGR of 6.26%, driven by due to their versatility, ease of swallowing, and ability to encapsulate complex or multi-part formulations.

By Mechanism

In 2025, the controlled release, controlled Oral Solid Dosage Contract Manufacturing Market had with 58.84% market share, as it can keep steady drug concentration over a prolonged time and help to achieve better treatment effects and patient compliance. The immediate release is the fastest-growing segment in the global Oral Solid Dosage Contract Manufacturing Market trend, owing to its fast-acting, low-cost, and broad application to acute and chronic diseases.

By End-Use

The large-sized companies control the global Oral Solid Dosage Contract Manufacturing industry with a significant market share of 58.80%, owing to their mature infrastructure, regulatory compliance, and global manufacturing capability. Medium & Small Size Companies segment plays a vital role, registering the fastest growth over the forecast period, fueled by their ease of control, cost effectiveness, and filling niches for pharmaceuticals at either the regional or specialty levels.

Get Expert-Led Insights for Your Business Strategy — Connect with Analysts Now @ https://www.snsinsider.com/request-analyst/9015

Oral Solid Dosage Contract Manufacturing Market Regional Insights:

In 2025, the North American region dominated the global oral solid dosage contract manufacturing industry and accounted for 32.50% of the overall revenue share owing to its highly concentrated presence of large pharmaceutical companies, sophisticated manufacturing setup, and stringent drug regulatory regime (FDA).

The Asia Pacific region is projected to grow with the fastest CAGR of 6.41% over the forecast period 2026-2033, owing to its economic production, growing pharma infrastructure, and increasing generics demand. 

Major Players Analysis Listed in the Oral Solid Dosage Contract Manufacturing Market Report:

• Catalent, Inc.
• Lonza Group AG
• Thermo Fisher Scientific
• Recipharm AB
• Cambrex Corporation
• Piramal Pharma Solutions
• Almac Group
• Aenova Group
• Famar Health Care Services
• Strides Pharma Science Ltd.
• Corden Pharma International
• Siegfried Holding AG
• NextPharma
• Jubilant Pharmova Limited
• Boehringer Ingelheim International GmbH
• Fareva Holding SA
• Hetero Drugs Limited
• Pfizer CentreOne
• Evonik Industries AG
• Akums Drugs and Pharmaceuticals Limited

Oral Solid Dosage Contract Manufacturing Market Recent Developments:

• In 2025, Catalent expanded its commercial-scale OSD manufacturing capabilities by upgrading its U.S. and European facilities with enhanced high-potency and controlled-release production lines to support growing demand for complex formulations.
• In 2025, Lonza strengthened its OSD portfolio by introducing an advanced formulation development platform designed to accelerate scale-up and improve bioavailability for poorly soluble compounds.

Purchase Comprehensive Oral Solid Dosage Contract Manufacturing Market Report – Single User PDF @ https://www.snsinsider.com/checkout/9015

Exclusive Sections of the Report (The USPs):

• CAPACITY UTILIZATION RATES – helps you understand average manufacturing capacity in billion tablets/capsules per year across major CMOs along with facility-level utilization rates. Also identifies the share of high-volume versus small-batch production to assess supply flexibility and scalability.
• OUTSOURCING & DEMAND INDICATORS – helps you evaluate the percentage of pharmaceutical companies outsourcing OSD manufacturing and the growth rate from small and emerging pharma firms. Also analyzes the proportion of generic versus branded drugs in outsourced production.
• QUALITY COMPLIANCE METRICS – helps you assess the percentage of facilities with FDA, EMA, and WHO GMP approvals along with audit frequency benchmarks. Also measures batch rejection and reprocessing rates due to quality deviations.
• COST & OPERATIONAL EFFICIENCY METRICS – helps you quantify average cost reduction achieved through outsourcing and lead time improvements enabled by advanced manufacturing technologies. Also evaluates turnaround time for formulation-to-production cycles.
• SUPPLY CHAIN DISRUPTION INDEX – helps you identify risks related to raw material sourcing, regulatory delays, and cross-border manufacturing dependencies. Also supports contingency planning through lead-time variability analysis.
• COMPETITIVE LANDSCAPE – helps you gauge the competitive strength of key OSD CMOs based on capacity scale, regulatory approvals, client portfolio mix, technological capabilities, and recent expansion initiatives.

Oral Solid Dosage Contract Manufacturing Market Report Scope:

Rising Demand for Oral Solid Dosage Contract Manufacturing Market Data, Our Full Report Trend Analysis @ https://www.snsinsider.com/reports/oral-solid-dosage-contract-manufacturing-market-9015

About Us:

SNS Insider is one of the leading market research and consulting agencies that dominates the market research industry globally. Our company’s aim is to give clients the knowledge they require in order to function in changing circumstances. In order to give you current, accurate market data, consumer insights, and opinions so that you can make decisions with confidence, we employ a variety of techniques, including surveys, video talks, and focus groups around the world.

CONTACT: Contact Data
Contact Us:
Rohan Jadhav - Principal Consultant
Phone: +1-315 636 4242 (US) | +44- 20 3290 5010 (UK)

Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. UKNewshour.com takes no editorial responsibility for the same.